IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 144 filers reported holding IMMUNOVANT INC in Q1 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,395,380 | +138.7% | 296,832 | +18.0% | 0.07% | +148.1% |
| Q2 2023 | $4,773,250 | -6.1% | 251,621 | -23.3% | 0.03% | -20.6% |
| Q1 2023 | $5,085,977 | +24.3% | 327,916 | +42.2% | 0.03% | 0.0% |
| Q4 2022 | $4,092,671 | +152.9% | 230,573 | +21.4% | 0.03% | +277.8% |
| Q4 2021 | $1,618,000 | -1.6% | 189,926 | +0.3% | 0.01% | -18.2% |
| Q3 2021 | $1,645,000 | -24.9% | 189,316 | -8.6% | 0.01% | -21.4% |
| Q2 2021 | $2,190,000 | -30.4% | 207,189 | +5.7% | 0.01% | -33.3% |
| Q1 2021 | $3,145,000 | +301.1% | 196,098 | +1055.7% | 0.02% | +162.5% |
| Q4 2020 | $784,000 | +3.4% | 16,968 | -21.2% | 0.01% | -11.1% |
| Q3 2020 | $758,000 | – | 21,535 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |